Cognitive dysfunctions in individuals with diabetes mellitus

키워드

참고문헌 (81)

1. McCrimmon RJ, "Diabetes and cognitive dysfunction", Lancet, 379, pp.2291~2299 (2012)
2. Kodl CT, "Cognitive dysfunction and diabetes mellitus", Endocr Rev, 29, pp.494~511 (2008)
3. Brands AM, "The effects of type 1 diabetes on cognitive performance: a me-ta-analysis", Diabetes Care, 28, pp.726~735 (2005)
4. Feinkohl I, "Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study", Diabetes Care, 37, pp.507~515 (2014)
5. Gold AE, "Recurrent severe hypoglycaemia and cognitive function in type 1 diabetes", Diabet Med, 10, pp.503~508 (1993)
6. Diabetes Control and Complications Trial, "Epidemiology of Diabetes Interventions and Complications Study Research Group", Long-term effect of diabetes and its treatment on cognitive function, 2007, pp.356, 1842~1852
7. Jacobson AM, "Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort", Diabetologia, 54, pp.245~255 (2011)
8. Wessels AM, "Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes", Eur J Pharmacol, 585, pp.88~96 (2008)
9. Asvold BO, "Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study", Diabetes Care, 33, pp.1945~1947 (2010)
10. Aye T, "The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children", Diabetes Care, 34, pp.1458~1462 (2011)
11. Northam EA, "Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset", Diabetes Care, 24, pp.1541~1546 (2001)
12. Ferguson SC, "Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia", Diabetes, 52, pp.149~156 (2003)
13. Ryan CM, "Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications", Diabetologia, 46, pp.940~948 (2003)
14. Ryan CM, "Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications", Diabetologia, 36, pp.329~334 (1993)
15. Wessels AM, "Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume", Diabetologia, 50, pp.1763~1769 (2007)
16. Skenazy JA, "Neuropsychological findings in diabetes mellitus", J Clin Psychol, 40, pp.246~258 (1984)
17. Schoenle EJ, "Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex", Diabetologia, 45, pp.108~114 (2002)
18. Cukierman T, "Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies", Diabetologia, 48, pp.2460~2469 (2005)
19. Curb JD, "Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance", Neurology, 52, pp.971~975 (1999)
20. Kuusisto J, "Association between features of the insulin resistance syndrome and Alzheimer’s disease independently of apolipoprotein E4 phenotype: cross sectional population based study", BMJ, 315, pp.1045~1049 (1997)
21. Leibson CL, "Risk of dementia among persons with diabetes mellitus: a population-based cohort study", Am J Epidemiol, 145, pp.301~308 (1997)
22. Luchsinger JA, "Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort", Am J Epidemiol, 154, pp.635~641 (2001)
23. Bruce DG, "Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study", Diabetes Res Clin Pract, 61, pp.59~67 (2003)
24. Gregg EW, "Cognitive and physical disabilities and aging-related complications of diabetes", Clin Diabetes, 21, pp.113~118 (2003)
25. Yaffe K, "Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women", J Nutr Health Aging, 10, pp.293~295 (2006)
26. Grodstein F, "Type 2 diabetes and cognitive function in community-dwelling elderly women", Diabetes Care, 24, pp.1060~1065 (2001)
27. Munshi M, "Cognitive dysfunction is associated with poor diabetes control in older adults", Diabetes Care, 29, pp.1794~1799 (2006)
28. Perlmuter LC, "Decreased cognitive function in aging non-insulin-dependent diabetic patients", Am J Med, 77, pp.1043~1048 (1984)
29. Reaven GM, "Relationship between hyperglycemia and cognitive function in older NIDDM patients", Diabetes Care, 13, pp.16~21 (1990)
30. Ryan CM, "Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes", Diabetes Care, 23, pp.1486~1493 (2000)
31. "Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial", Ann Intern Med, 124, pp.379~388 (1996)
32. Duckworth W, "Glucose control and vascular complications in veterans with type 2 diabetes", N Engl J Med, 360, pp.129~139 (2009)
33. Action to Control Cardiovascular Risk in Diabetes Study Group, "Effects of intensive glucose lowering in type 2 diabetes", N Engl J Med, 358, pp.2545~2559 (2008)
34. Williamson JD, "The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods", Am J Cardiol, 99, pp.112i~122i (2007)
35. Ding J, "Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study", Diabetes, 59, pp.2883~2889 (2010)
36. Reijmer YD, "Cognitive dysfunction in patients with type 2 diabetes", Diabetes Metab Res Rev, 26, pp.507~519 (2010)
37. Vanhanen M, "Cognitive function in an elderly population with persistent impaired glucose tolerance", Diabetes Care, 21, pp.398~402 (1998)
38. Kanaya AM, "Change in cognitive function by glucose tolerance status in older adults:a 4-year prospective study of the Rancho Bernardo study cohort", Arch Intern Med, 164, pp.1327~1333 (2004)
39. Biessels GJ, "Ageing and diabetes: implications for brain function", Eur J Pharmacol, 441, pp.1~14 (2002)
40. Brownlee M, "The pathobiology of diabetic complications: a unifying mechanism", Diabetes, 54, pp.1615~1625 (2005)
41. Klein JP, "The brain in diabetes: molecular changes in neurons and their implications for end-organ damage", Lancet Neurol, 2, pp.548~554 (2003)
42. Toth C, "Diabetes, leukoencephalopathy and rage", Neurobiol Dis, 23, pp.445~461 (2006)
43. Reske-Nielsen E, "Pathological changes in the central and peripheral nervous system of young long-term diabetics. II. The spinal cord and peripheral nerves", Diabetologia, 4, pp.34~43 (1968)
44. Reske-Nielsen E, "Pathological changes in the central and peripheral nervous system of young long-term diabetics: i. diabetic encephalopathy", Diabetologia, 1, pp.233~241 (1966)
45. McCall AL, "The impact of diabetes on the CNS", Diabetes, 41, pp.557~570 (1992)
46. Johnson PC, "Thickened cerebral cortical capillary basement membranes in diabetics", Arch Pathol Lab Med, 106, pp.214~217 (1982)
47. Biessels GJ, "Cerebral function in diabetes mellitus", Diabetologia, 37, pp.643~650 (1994)
48. Kushner M, "Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome", Ann Neurol, 28, pp.129~135 (1990)
49. Coyle JT, "Oxidative stress, glutamate, and neurodegenerative disorders", Science, 262, pp.689~695 (1993)
50. Li PA, "Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia", Stroke, 31, pp.183~192 (2000)
51. Auer RN, "Hypoglycemic brain damage", Forensic Sci Int, 146, pp.105~110 (2004)
52. Patrick AW, "Fatal hypoglycaemia in insulin-treated diabetes mellitus: clinical features and neuropathological changes", Diabet Med, 7, pp.349~354 (1990)
53. Comi G, "Evoked potentials in diabetes mellitus", Clin Neurosci, 4, pp.374~379 (1997)
54. Siesjö BK, "Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis", J Cereb Blood Flow Metab, 9, pp.127~140 (1989)
55. Wieloch T, "Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist", Science, 230, pp.681~683 (1985)
56. de la Monte SM, "Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease", J Alzheimers Dis, 7, pp.45~61 (2005)
57. de la Monte SM, "Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis", Curr Opin Investig Drugs, 10, pp.1049~1060 (2009)
58. Broughton SK, "Large-scale generation of highly enriched neural stem-cell-derived oligodendroglial cultures: maturation-dependent differences in insulin-like growth factor-mediated signal transduction", J Neurochem, 100, pp.628~638 (2007)
59. de la Monte SM, "Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer’s disease", Drugs, 72, pp.49~66 (2012)
60. Steen E, "Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease--is this type 3diabetes?", J Alzheimers Dis, 7, pp.63~80 (2005)
61. Rivera EJ, "Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease:link to brain reductions in acetylcholine", J Alzheimers Dis, 8, pp.247~268 (2005)
62. Watson GS, "Insulin increases CSF Abeta42 levels in normal older adults", Neurology, 60, pp.1899~1903 (2003)
63. Gasparini L, "Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling", J Neurosci, 21, pp.2561~2570 (2001)
64. Gasparini L, "Does insulin dysfunction play a role in Alzheimer’s disease?", Trends Pharmacol Sci, 23, pp.288~293 (2002)
65. Messier C, "The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer’s disease", Neural Plast, 12, pp.311~328 (2005)
66. Schubert M, "Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation", J Neurosci, 23, pp.7084~7092 (2003)
67. Schubert M, "Role for neuronal insulin resistance in neurodegenerative diseases", Proc Natl Acad Sci U S A, 101, pp.3100~3105 (2004)
68. Lester-Coll N, "Intracerebral streptozotocin model of type 3 diabetes:relevance to sporadic Alzheimer’s disease", J Alzheimers Dis, 9, pp.13~33 (2006)
69. Weinstock M, "Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity", J Neural Transm (Vienna), 111, pp.347~366 (2004)
70. Welsh B, "Effects of streptozotocin-induced diabetes on acetylcholine metabolism in rat brain", Neurochem Res, 16, pp.453~460 (1991)
71. Stone WS, "Blood glucose and brain function: interactions with CNS cholinergic systems", Behav Neural Biol, 50, pp.325~334 (1988)
72. Craft S, "Memory improvement following induced hyperinsulinemia in Alzheimer’s disease", Neurobiol Aging, 17, pp.123~130 (1996)
73. Kamal A, "Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression", Neuroscience, 90, pp.737~745 (1999)
74. Palovcik RA, "Insulin inhibits pyramidal neurons in hippocampal slices", Brain Res, 309, pp.187~191 (1984)
75. Craft S, "Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype", Psychoneuroendocrinology, 28, pp.809~822 (2003)
76. Kálmán J, "Lactate infusion fails to improve semantic categorization in Alzheimer’s disease", Brain Res Bull, 65, pp.533~539 (2005)
77. Craft S, "Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender", Neuroendocrinology, 70, pp.146~152 (1999)
78. de la Monte SM, "Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer’s disease", J Alzheimers Dis, 10, pp.89~109 (2006)
79. Watson GS, "Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study", Am J Geriatr Psychiatry, 13, pp.950~958 (2005)
80. Risner ME, "Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease", Pharmacogenomics J, 6, pp.246~254 (2006)
81. Cao B, "Comparative efficacy and acceptability of antidiabetic agents for Alzheimer’s disease and mild cognitive impairment: a systematic review and network meta-analysis", Diabetes Obes Metab, 20, pp.2467~2471 (2018)

관련 논문AI추천